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ABSTRACT 
Being able to detect if drugs were used in the commission of a 
crime, and if so what drugs, is of great importance.  For many cases 
these tests can be carried out on an intimate blood or urine sample (one 
recovered directly from the subject in question), however this may not 
always be the case.  In cases where a dried bloodstain is the only source 
of biological material, identifying the presence of drugs affecting an 
individual at the time of stain deposition has not been well studied. 
Towards this goal, two methods of detection of drugs of abuse in 
dried bloodstains were evaluated: lateral flow immunoassay test cards 
and gas chromatography-mass spectrometry.  Stains were created using 
certified drug-free blood spiked with analytes of interest, and were then 
extracted and introduced into each testing method. 
Both methods proved effective for the detection of one or two of the 
five chosen analytes (amphetamine, cocaine, morphine 3-ß-D-
glucuronide, phencyclidine and 11-nor-Δ9-tetrahydracannabinol), even 
vi 
after 24 hours of drying at room temperature.  With further method 
optimization and more thorough method development, these methods 
may, in the future, be effectively used for drug detection in forensic 
stains.  However, neither method evaluated in this study was able to 
detect all of the drugs tested. 
vii 
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1. INTRODUCTION 
1.1. Drug Use and Abuse 
The use of mind and body altering substances has been a part of 
human society for millennia [1].  Plants and fungi have been used for 
their curative purposes as well as for their mind-altering abilities for 
thousands of years [1].  
Merriam-Webster Dictionary defines a drug as “a substance other 
than food intended to affect the structure or function of the body” [2].  
This definition encompasses many compounds that are used regularly in 
hospitals and homes the world over.  Legitimate medical uses exist for 
many of these compounds, including analgesics, anti-psychotics, 
sedatives, stimulants and anti-depressants. However, there are 
compounds that are used not for their medical benefits, but for 
recreation, and the two groups are not mutually exclusive. Those 
substances used for recreational purposes pose a threat to public health 
and safety in the United States (US), as well as in countries all over the 
world.  The Centers for Disease Control and Prevention (CDC) reported 
over 47,000 deaths in the US from drug overdose in 2014 alone, a 14 
percent increase from the previous year [3].  Deaths due to overdose are 
not the only public health worries associated with drug use.  Drugs can 
also be used to assist, or perpetuate, a criminal act such as operation of 
a motor vehicle under the influence of a drug [4], or drug facilitated 
2 
sexual assault (DFSA) [5].  Being able to detect and identify drugs used 
in the commission of a crime is of great importance.  For many cases 
these tests can be carried out on an intimate blood or urine sample (one 
recovered directly from the subject in question), however this may not 
always be the case. Some drugs are eliminated from the body rapidly, 
making detection difficult or impossible after a relatively short period of 
time [6].  Given that many victims of sexual assault, for example, may 
not report the crime immediately [7], by the time a test is performed 
there may no longer be any trace of the drug(s) used to subdue the victim 
left in his or her body.  If the assault turned violent, it is possible that 
blood or other bodily fluids may have been left on the clothing of the 
victim or of his or her attacker.  This blood, having been potentially 
deposited at the time of the crime, may still contain the drugs and their 
metabolites under whose effects either the victim or attacker may have 
been at the time of the assault.  With this in mind, it was hypothesized 
that, if these stains could be tested, the presence of a drug in the blood 
at the time of the crime might be detectable, even in the absence of a 
traditional drawn blood sample. 
1.1.1. Drug Classification and Scheduling 
 Given the public health risks associated with the use and abuse of 
drugs the US, under President Richard Nixon, consolidated all existing 
federal drug laws (over 200 individual laws) into one set of regulations, 
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called the Controlled Substances Act (CSA), in 1970 [8].  The CSA 
provides guidelines for the manufacture, distribution, and categorization 
of drugs of abuse in the US.  Under the CSA, drugs are sorted into 
“schedules” based on factors including known health and medical uses, 
as well as potential for abuse and development of dependency [8].  
Schedule I includes drugs that have no accepted, legitimate, medical use, 
and have a high potential for addiction and abuse. Schedule II drugs are 
those that have a high potential for addiction and abuse, but also have a 
generally accepted, legitimate medical use. As Schedule number 
increases, medical use increases, and addiction and abuse potential 
decreases. There are a total of five drug Schedules under the CSA [8]. 
 The federal scheduling system allows for drugs to be added or 
moved without rewriting legislature, as well as supplies guidelines for 
charging offenders based on the type and quantity of an illicit substance 
they are carrying or under the influence of [8]. For example, the 
possession of a Schedule V drug may result in a misdemeanor charge 
with a possible one-year prison sentence, while the possession of a 
Schedule I drug could result in multiple years in prison and a large 
monetary fine.  As a result, it is important to know what drugs a person 
is carrying or under the influence of, because it may drastically affect the 
charges brought against him or her [9]. 
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1.2 . Drugs of Interest 
 A forensic laboratory will receive samples for toxicological analysis 
including blood, urine, tissue samples and other biological matrices.  
These matrices can be used for analysis and may contain drugs and/or 
metabolites.  In a typical forensic laboratory these compounds can range 
from predator drugs (used for drug-facilitated sexual assault) such as 
gamma-hydroxybutyrate (GHB), to club drugs, used to enhance the 
social experience at a club or party, such as ecstasy or phencyclidine.  
Drug identification can be important in not only determining the 
circumstances of a case, but also may have an effect on the severity of 
charges brought against the subject [10].  The drugs tested in this study 
were chosen based on availability of testing cards as well as published 
concentrations in blood and urine. 
1.2.1. Amphetamine 
Amphetamine is a Schedule III  drug that is used for its stimulant 
effects [11] and a Schedule II drug when prepared as a mixture such as 
with Adderall.  It has a legitimate medical use in the treatment of 
disorders such as attention deficit disorder and attention deficit 
hyperactivity disorder [12], narcolepsy, obesity, and hypotension [11]. 
Originally synthesized in 1887, amphetamine was not used 
medically until the 1920s when it was found to have positive effects 
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when administered to patients with asthma via inhaler, facilitating easier 
breathing by dilating bronchioles in the lungs.   By the 1950s the drug 
had been formulated into a tablet form, and had become exceedingly 
popular.  Users ranged from teenagers trying to get a high to soldiers in 
World War II trying to stay awake [13]. 
1.2.1.1. Methods of Administration 
 Amphetamine can be inhaled using an inhaler, swallowed in a pill 
or tablet form, snorted in a powder form, smoked, or injected 
intravenously [14].  In its sulfate salt tablet form it is commonly 
administered in a dosage ranging from 5 milligrams (mg) to 15 mg.  A 
chronic user may inject him- or herself with up to 2000 mg intravenously 
a day to maintain the energetic high received from amphetamine use 
[11]. 
1.2.1.2. Effects on the Mind and Body 
 As a stimulant, amphetamine increases alertness and focus.  Heart 
rate is increased as is breathing rate. Amphetamine acts as a competitive 
inhibitor of dopamine reuptake and facilitates the release of dopamine 
back into the synaptic cleft as well as inhibiting dopamine degradation 
while also activating dopamine synthesis [15].  These characteristics, 
combined, result in high levels of dopamine, a neurotransmitter affecting 
cognition, information processing, and behavior [16], in the synaptic 
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cleft, resulting in the drug’s stimulant nature.  Death by overdose is rare 
but can be caused by cardiotoxicity of the drug, presenting with 
cardiomyopathy, arrhythmia, or cardiac failure [17].  
1.2.1.3. Metabolism and Elimination 
 During metabolism, amphetamine is converted mostly into 
phenylacetone via deamination, and is then further converted, by 
oxidation, to benzoic acid and eliminated in urine [11] . A small portion 
of an amphetamine dose is also converted to norephedrine.  
Approximately 30% of a dose will be excreted in urine, unchanged, within 
a day of administration [11, 18]. 
 
Figure 1. Amphetamine Metabolism. Metabolic breakdown of amphetamine by the 
human body [11].  Created using emolecules.com. 
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1.2.2. Cocaine 
 Cocaine is a psychoactive stimulant that is well known for being 
highly addictive. An extract of coca leaves, from the Erythroxylon coca 
plant, cocaine has played a role in many South American cultures prior 
to its appropriation as a common recreational drug around the world 
[19].  Leaves from the coca plant can contain cocaine in amounts up to 
2% by weight [11]. Cocaine was first isolated in 1855 into its pure form 
[11].  Under the CSA, cocaine is considered Schedule II, reflecting its 
high potential for abuse and addiction [8].  It does, however, have a 
legitimate medical use as a mucosal anesthetic [13]. 
1.2.2.1. Methods of Administration 
 Commonly found in a hydrochloride salt form, cocaine be 
insufflated (inhaled through the nose or “snorted”), or dissolved in water 
and then injected intravenously [13].  The dissolved form may also be 
applied topically when used as a local anesthetic [11].  If prepared in a 
“crack” or “freebase” form, by processing with ammonia or sodium 
bicarbonate, the drug will lose its water-solubility.  This form can be 
heated and the resulting fumes can be inhaled (common dosages range 
from 10 to 120 mg) [11].  It is also possible to chew, or make a tea with, 
the leaves of the coca plant to extract the drug directly from its source 
[13]. 
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1.2.2.2. Effects on the Mind and Body 
 Cocaine acts as a central nervous system stimulant, as well as a 
local anesthetic.  Common effects include euphoria, increased energy, 
and a heightened sense of alertness.  Cocaine interferes with the 
reuptake of dopamine in the nucleus accumbens, resulting in a build-up 
of dopamine in the synaptic cleft, leading to a euphoric state [13].  
Prolonged use may result in irritability, anxiety, and sometimes even 
auditory hallucinations [13]. 
1.2.2.3. Metabolism and Elimination 
 Cocaine is converted to ecgonine methyl ester in the blood by 
cholinesterase [20].  Cocaine may also be hydrolyzed into 
benzoylecgonine and further broken down into ecgonine [11].  Most of a 
dose of cocaine will be eliminated in the urine within 24 hours of 
administration as a combination of unchanged cocaine (1%-9%), 
benzoylecgonine (35%-54%), and ecgonine methyl ester (32%-49%) [11].  
When alcohol (ethanol) is consumed around the time of cocaine 
introduction, the presence of the alcohol will alter the way the human 
liver breaks down cocaine, resulting in another analyte: cocaethylene.  
Approximately 24% ± 11% of intravenously injected, 34% ± 20% of oral 
dosage, or 18% ± 11% of smoked cocaine can be converted to 
cocaethylene in the presence of alcohol [9, [21]. 
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Figure 2. Cocaine Metabolism. Metabolic pathway of cocaine in the human body [11]. 
Created using emolecules.com. 
 
1.2.3. Morphine 
Morphine is an opioid that can be used as a narcotic analgesic.  As 
a major component of opium, morphine has been in use by humans for 
thousands of years with records showing use as far back as 3400 BC in 
Mesopotamia [22]. Originally found in the extracts from the opium 
poppy, morphine itself was isolated in 1806. Since then it has been used 
medically for the treatment of pain [11].  Morphine is considered a 
Schedule II drug under the CSA [8]  due to its high potential for addiction 
and abuse, in conjunction with its legitimate medical use.  Morphine is 
also a breakdown product of other opioid drugs, meaning that morphine 
may be present in a system if the subject was using other opioid drugs 
such as heroin [23]. 
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1.2.3.1. Methods of Administration 
 When administered in a hospital setting, morphine is almost 
always injected either subcutaneously or intramuscularly in dosages 
starting at 10 milligrams per 70 kilogram (mg/kg) [11].  An oral 
preparation is also available; however, oral administration does result in 
diminished efficacy and some unpredictability.  Poppy seeds are also 
known to contain a small amount (4-200mg/kg) of morphine naturally, 
resulting in a small oral dose when any poppy seed-containing food is 
consumed [11]. 
1.2.3.2. Effects on the Mind and Body 
 Morphine acts on multiple groups of opioid receptors in the brain 
with varied results.  Activation of mu receptors, found in the brainstem 
and the thalamus, result in euphoria, pain relief, sedation, and 
respiratory depression.  Activation of kappa opioid receptors has similar 
effects including pain relief, sedation, and hypopnea (loss of breath).  
Delta receptors, when activated, result in analgesic and antidepressant 
effects [24]. 
 Morphine use has many possible side effects ranging from nausea, 
vomiting, and constipation, to hallucinations, delirium, dizziness, and 
confusion.  In large doses death is also possible due to any combination 
of adverse effects including pulmonary edema and respiratory depression 
11 
[11, 24]. Morphine is a Schedule II drug, and like other opiates, does 
have a high risk of addiction and dependence [8].  
1.2.3.3. Metabolism and Elimination 
 Morphine itself is a metabolite of other opioids such as 6-acetal 
morphine and heroin, as well as being a drug in its own right.  Morphine 
is rapidly broken down during first pass metabolism, the majority being 
converted, eventually, into morphine-3-glucuronide. 87% of a dose of 
morphine will be eliminated in the urine at 72 hours after 
administration. Of that portion, 75% of it will be in the morphine-3-
glucuronide form. Other pathways of elimination for morphine-3-
glucuronide include bile excretion, resulting in the eventual elimination 
in fecal matter.  Other metabolites are also found in urine at much lower 
concentrations, including normorphine, morphine-6-glucuronide, 
morphine-3-ethereal sulfate, and morphine-3,6-glucuronide (Figure 3) [11, 
23]. 
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Figure 3. Morphine Metabolism. Metabolic pathway of morphine in the human body 
[11]. Created using emolecules.com 
1.2.4. Phencyclidine 
 First synthesized in 1926, PCP was developed for human use in 
the 1950s as an anesthetic that could be administered intravenously 
[25].  The use of the drug in humans was discontinued in the 1960s due 
to the incidence of side effects including delirium, hallucinations, and 
mania [25].  The drug is still used in veterinary medicine [13].  PCP is 
considered a Schedule II drug under the CSA, meaning that it has a high 
potential for abuse, and its use may lead to physical or psychological 
dependence [8]. 
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1.2.4.1. Methods of Administration 
PCP can be self-administered in a number of ways: it can be 
ingested in tablet or pill form, it can be found in a powder form, meant to 
be insufflated, it can be injected intravenously, or it can be smoked. For 
the purposes of smoking, a liquid preparation is sprayed onto a plant 
substance such as marijuana or oregano and then smoked (drugs.com) 
[11]. 
As controlled study data is limited due to its psychoactive effects 
on participants, blood concentration data are based mostly on case study 
information. Between 26 arrested subjects, the average blood 
concentration of PCP was 75 nanograms per milliliter (ng/mL) with a 
range from 7 ng/mL to 240 ng/mL. PCP has an estimated half-life of 11-
13 hours in the body [11]. 
1.2.4.2. Effects on the Mind and Body 
PCP acts as a noncompetitive agonist for the NMDA/glutamate 
receptor as well as interacting with nicotinic, dopamine, and opioid 
receptors.  Administration of PCP results in a feeling of detachment in 
subjects as well as a loss of coordination and slurred speech.  
Extremities may also become numb under its effects.  This is 
accompanied by auditory hallucinations, image distortion, and in some 
cases, amnesia [26]. 
14 
 Physiologically, the use of PCP may result in an increased heart 
rate, and increased blood pressure, as well as an accelerated shallow 
breathing rate. This is accompanied by flushing and sweating.  When a 
high dose is administered, blood pressure, heart rate, and breathing rate 
all begin to drop, and the subject may be afflicted with nausea, vomiting, 
and dizziness.  While a high does of PCP can result in coma or death, 
most deaths due to PCP use are caused by accidental injury or suicide 
[13]. 
 As a Schedule II drug, PCP has a high potential for abuse and 
addiction [8].  Use may result in psychological dependence, resulting in 
cravings and memory loss, as well as depression and weight loss.  These 
effects may still be experienced for months after PCP use has stopped 
[13].  
1.2.4.3. Metabolism and Elimination 
 PCP is broken down into two inactive compounds via oxidative 
metabolism. These metabolites are 4-phenyl-4-piperidinocyclohexanol 
and 1-(1-phenylcyclohexyl)-4-hydroxypiperidine (Figure 4).  Both are 
excreted in the urine as glucuronide conjugates.  Unchanged PCP is also 
eliminated in the urine as well as in fecal matter [11]. 
15 
 
Figure 4. Phencyclidine Metabolism.  Metabolic pathway of phencyclidine in the 
human body [11]. Created using emolecules.com 
 
1.2.5. Tetrahydrocannabinol 
Tetrahydrocannabinol (THC, Δ9-THC) is the primary active 
component found in Cannabis sativa or the marijuana plant.  It can be 
found in multiple parts of the plant itself in concentrations up to 12% by 
weight [11].  Marijuana is the most popular illicit drug used in the US.  
Recently, multiple states have legalized it for recreational, as well as 
medical use [27].  Despite this, it is still considered a Schedule I 
substance under the CSA, indicating that it poses a high risk of 
addiction and dependence and has no legitimate medical use [8]. 
1.2.5.1. Methods of Administration 
 The most common method of administration is smoking. This is 
achieved through a variety of methods including rolled cigarettes 
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(referred to as “joints”), water pipes (“bongs”), and cigars, emptied of their 
tobacco and filled with dried Cannabis leaves (called “blunts”).  THC can 
also be incorporated into foods, such as brownies or cookies, utilizing 
THC-infused ingredients like butters or oils.  THC can also be infused 
into waxes, which are then smoked through a bong [11, 27]. 
1.2.5.2. Effects on the Mind and Body 
 Δ9-tetrahdrocannabinol acts on cannabinoid CB1 receptors on pre-
synaptic nerve cells in the brain.  These CB1 receptors interact with G-
proteins, resulting in inhibition of voltage-gate calcium channels and 
sodium channels in the affected neuron. Potassium channels are 
activated instead of inhibited.  When combined, these 
activation/inhibition effects result in the sought after sensation: 
euphoria [28]. 
 The use of marijuana over a short term results in euphoria, altered 
perception (seeing brighter colors, altered sense of time, etc.), impaired 
movement and reaction time, and memory impairment [27].  Long-term 
use has been shown to affect brain development, memory, learning 
abilities, and thinking capacity [27]. 
1.2.5.3. Metabolism and Elimination 
 Δ9-THC is metabolized into a group of inactive compounds 
including 11-nor-9-carboxy-THC and 8- β-hydroxy-THC, as well as 11-
carboxy-THC (Figure 5).  About 70% of a dosage is excreted within 72 
17 
hours of administration: 30% in urine and 40% in fecal matter.  11-
carboxy-THC and its conjugates have been detected in urine samples for 
several weeks after a single dosage has been taken [11]. 
 
Figure 5. Tetrahydrocannabinol Metabolism. Metabolic pathway of 
tetrahydrocannabinol in the human body [11]. Created using emolecule.com. 
1.3. Methods of Detection 
1.3.1. Testing Matrices 
 In a forensic setting, it is possible to come across a range of 
biological samples. These can include, but are not limited to, blood, 
urine, saliva, semen, and hair.  The most common samples found in 
these settings are saliva and blood [29].  When these samples are found, 
they are likely to be nearly or fully dried, due to the time lapse between 
deposition and arrival of a response team.  In clinical settings, a patient 
may be tested to confirm compliance with medication use or for 
workplace testing purposes. This is most commonly done using a urine 
11-carboxy-THC11-hydroxy-THCTHC
8-hydroxy-THC 8,11-dihydroxy-THC
conjugation
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test [30], as obtaining a fresh urine sample is less invasive, and easier, 
than drawing blood. As a result there are commercially available urine 
testing kits available online.  
1.3.1.1. Blood 
 Blood is the main transport system for fluids in the human body.  
It carries nutrients, oxygen (necessary for cellular respiration), cells that 
carry out immune response, waste products (such as carbon dioxide) and 
small molecules including drugs and their metabolites.  An adult human 
body typically contains five or six liters of blood, making up 
approximately 7%-9% of body weight.  The components of blood can be 
broken down into two major categories: the cellular components, and the 
liquid or plasma components [31]. 
 The cellular portion of blood encompasses erythrocytes (red cells), 
leucocytes (white cells), and thrombocytes (platelets).  The red blood cells 
are responsible for transporting oxygen from the lungs to the tissues by 
binding it to hemoglobin.  These cells are also responsible for the 
characteristic reddish color of blood.  White blood cells function as 
protectors, working within the immune system to detect, target, and 
destroy foreign, or even native, material that poses harm to the body, 
such as a disease agent or cancer cell.  When an injury is sustained, 
platelets go to work clotting the blood to reduce fluid loss [31]. 
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 The plasma portion of blood is straw-colored clear liquid that 
carries blood cells and other components through the veins and arteries, 
delivering them to where they are needed, or can be eliminated.  The 
dissolved components carried by blood include proteins, nutrients, 
drugs, and drug metabolites [31].  When drugs are introduced into the 
body they will be taken up by the blood, whether by direct injection or by 
absorption at the site of introduction (nasal mucosa, stomach after 
ingestion), and mixed with the systemic venous blood. A portion of the 
total blood output is brought through the liver.  The liver helps to break 
down drugs into forms more usable by, and/or less toxic to, the human 
body. This results in the presence of metabolites as, as well as parent 
drugs, in the blood plasma [32]. 
 When blood is released from the body at a crime scene, it may 
leave a stain if left undisturbed. Some attempts at cleaning may not even 
fully remove a blood stain from a crime scene [29].  As such, blood is a 
useful medium for forensic testing ranging from DNA typing to drug 
testing. 
1.3.1.2. Urine 
 Urine is a form of liquid waste, made up mostly of water, 
electrolytes, and other compounds that the body is trying to eliminate.  
This includes chemicals that may naturally build up in the system over 
time, as well as any toxins or foreign substances, like drugs.  Urine is 
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created in the kidneys, where blood flows through the glomerulus, and 
any filterable components will be removed from blood.  This filtered 
fraction then proceeds through structures deeper within the kidney and 
is concentrated to avoid excessive fluid loss, while maintaining waste 
elimination.  The resulting fluid is then expelled from the body, along 
with all of the waste products it carries.  Some drugs and their 
metabolites may be glucornidated at this point, which may inhibit 
reuptake, leading to the presence of an analyte in urine that would not 
be found in blood [33].  All analytes chosen for this study have been 
shown to show up in both urine and blood [11]. 
1.3.2. Extraction Solvents 
 When working with any sample, extraction of the components of 
interest may be necessary.  This can be achieved by exploiting differences 
between the components of interest and the other components of the 
sample matrix.  Solubility is one such possible difference: some 
compounds are soluble in polar solvents, while others may be more 
readily extracted using a non-polar, organic solvent [10].  
1.3.2.1. Water 
 Water is a clear, odorless, tasteless liquid that is essential for life 
in both animals and plants.  Water is a polar solvent with a boiling point 
at 100 degrees Centigrade (°C) and a melting point at 0°C [34].  Water 
can be augmented utilizing weak or strong acids and bases to create 
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buffers, solutions that will resist changes in pH, which can be used 
effectively for extraction purposes [35]. 
1.3.2.2. Methanol 
 Methanol is a colorless, highly flammable liquid with a pungent 
odor.  Also known as methyl or wood alcohol, methanol is regularly used 
in chemical synthesis, with a boiling point at 64.7°C and a melting point 
at -97.8°C.  It is a polar organic solvent and, as such, is useful for the 
extraction of polar compounds [36].   
1.3.2.3. Chloroform 
 Chloroform is a colorless, volatile liquid commonly found in 
laboratories being used as a solvent.  Historically, chloroform has been 
used as an anesthetic but was banned in the US after worries about its 
carcinogenicity were raised. Chloroform is a non-polar, organic solvent 
with a boiling point of 61.17°C and a melting point of -63.41°C, making it 
useful in the extraction of non-polar analytes [37]. 
1.3.3. Lateral Flow Immunoassay Testing 
 As the name implies, immunoassay testing utilizes antibodies 
(immune response products used for tagging immune system targets) 
and their interactions with the analyte of interest to indicate the 
presence or absence of that target.  Antibodies can be produced by 
different methods, resulting in different antibody populations.   
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The first method produces polyclonal antibodies. This is achieved 
by introducing the analyte of interest, or antigen, into a living host. 
Multiple lymphocytes that are part of the host’s immune system will 
produce antibodies against the antigen, allowing blood to be harvested 
from the host and the antibodies to be separated out, yielding multiple 
antibody types that will target the analyte of interest.   
Monoclonal antibodies are produced by harvesting spleen cells 
from a host that has been inoculated with the antigen.  These spleen 
cells are fused to myeloma cells, forming hybridomas. These hybridomas 
proliferate indefinitely and clones grow from a single cell, producing a 
single type of antibody.  This allows for more specific selection of 
antibodies but requires more time and resources for production [29].  
 For the purposes of lateral flow immunoassay testing, these 
antibodies are placed in multiple locations along a test strip consisting of 
an absorbent material (membrane).  Some are free floating in the sample 
well and will be carried with the sample as it moves along the strip.  
These mobile antibodies are dye-labeled to allow visualization of results.  
Other antibodies will be bound to the strip at a control region to confirm 
the test is working.  There are two types of immunoassays that branch 
off from here.  The first, which is most commonly found in forensic 
serology testing, is a sandwich-style lateral flow immunoassay, which 
utilizes an analyte-specific antibody bound in a second (test) area of the 
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test strip.  The second is the competitive binding form, which utilizes a 
free-floating antibody in the sample well that will bind to the analyte of 
interest prior to migrating up the strip.  If enough of the antibodies are 
left unbound a secondary line will appear on the test, indicating a 
negative result.  Visually, the main difference between tests is the 
number of lines indicating a positive result (one line for competitive, two 
for sandwich) and a negative result (two lines for competitive, one for 
sandwich) (Figure 6) [38].  
 
Figure 6. Lateral Flow Immunoassay Cards. Both competitive binding and sandwich 
style lateral flow immunoassay cards. 
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1.3.4. Gas Chromatography 
 Gas Chromatography (GC) is a method of separation by selective 
partitioning.  This is accomplished by volatilizing the compounds of 
interest in a solution, introducing the sample into a gas stream of inert 
gas (helium for example) and passing it through a capillary column.  The 
column is coated on the inside with silica-based sorbent material 
designed to separate analytes based on chemical and physical 
characteristics.  At the end of the column the analytes are introduced 
into a detector (a mass spectrometer or other detector), where a signal is 
recorded and saved for analysis [10, 39]. 
 The basic components of a GC unit are as follows: a carrier gas 
container with flow control, an injection port, a sample splitter, the 
capillary column, an oven, and a detector.  The carrier gas container and 
flow controller provide the gas (mobile phase) required for the GC to 
function.  The chosen gas must be chemically inert as to avoid any 
unwanted chemical reactions occurring that might result in false data.  
The injection port acts the point of introduction for the sample and is 
usually heated to vaporize the sample instantaneously for introduction 
into the column.  It is possible to use a cool inlet injection method if 
there is concern of analyte thermal instability.  Many GCs have two 
injection types: a split injection that only carries a small portion of the 
sample into the next step to avoid overloading the column, and a 
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splitless injection in which the entire volume is injected into the capillary 
column. Similar molecules will not separate from each other as easily as 
molecules that are drastically different in chemical and physical 
characteristics.  Some of the data received from the GC comes in form of 
retention times (RT), which represent how long a specific molecule took 
to travel from the injection port to the end of the capillary column.  RTs 
should remain relatively consistent across runs for a given analyte.  At 
the end of the column, the analytes flow to a detector, which will supply 
more information on the identity of those analytes (Figure 7)[10]. 
 
Figure 7. Components of a Gas Chromatograph. Components of a gas chromatograph 
including the carrier gas container, the flow controller, the sample injector, the oven, 
the column, and the detector. 
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1.3.4.1. Derivitization 
 Some compounds do not separate or analyze well by GC in their 
unaltered forms.  For these molecules, one possible solution is 
derivitization, which introduces a set of reagents that will change the 
chemical structure of the molecule and make it more suitable for 
separation by GC by altering volatility or stationary phase interactions.  
These include, but are not limited to, acylation by pentafluoropropionic 
acid anhydride (PFPA) or Pentafluoropropanol (PFPOH), or silylation by 
N,O-Bistrifluoroacetamide (BSTFA) or N-Methyl-N-(trimethylsilyl) 
trifluoroacetamide (MSTFA).  By changing the functional groups and 
chemical properties of these analytes, they can become more likely to be 
separated by GC [40]. 
1.3.5 Mass Spectrometry 
 Mass spectrometry (MS) is a sensitive detection method for 
analytes of interest [41].  For detection purposes the MS produces ions of 
the molecules introduced into it, and then proceeds to compare the ratio 
of molecular mass to net charge to determine the identity of an analyte 
[10].  When a sample has been separated by a method such as GC, and 
introduced into an MS, the first thing that occurs is ionization.  In the 
ion source of the MS, the sample is bombarded with a beam of high-
energy electrons.  This will result in the ionization, or charging, of 
molecules in the sample.  These charged molecules are then introduced 
27 
into the magnetic field.  For the purposes of this experiment the mass 
spectrometer utilized a quadrupole: a system of four parallel magnetic 
bars arranged around the path of flight.  The magnetic field will result in 
the deflection of charged ions, with the trajectory of ions of lower mass to 
charge ratio being affected more than those of high mass to charge ratio.  
This allows the MS to detect the differences and categorize the ions based 
on this information.  Multiple quadrapoles can be added in series, which 
can allow for not just the detection of the parent ion but also of ion 
fragments.  This data can be recovered in “scan” mode or “selected ion 
monitoring (SIM)” mode.  Scan mode reads all data that the MS is 
receiving, giving a full mass spectrum for each point in time.  SIM mode 
allows the analyst to select specific ions to search for and will only give 
data including those mass fragments.  Each molecule has a manner in 
which it is most likely to fracture under the ionization beam.  With the 
detection of the precursor and product ions, the MS is able to give a 
profile for a particular molecule that can be compared between standards 
and samples to determine if an analyte of interest is present or not.  An 
extracted ion chromatogram can be used to search for specific mass 
fragments in a GC run, allowing the analyst to look for ions affiliated 
with the analyte of interest [10, 42].  The combination of mass fragments 
and RTs from the GC can be used to indicate the presence of a particular 
analyte in a sample. 
28 
1.4 Purpose of this Research 
 There is a delay inherent in any criminal investigation.  A crime is 
very unlikely to be investigated at the time at which it occurs.  The crime 
scene team must be contacted and travel to the scene before 
investigation can begin.  This process can occur swiftly if law 
enforcement is contacted immediately, but may incur a long delay if 
contact is not immediate or resources are not readily available. With 
respect to body fluid stains such as blood or urine, this means that these 
stains are likely to be dried by the time they are collected and 
subsequently analyzed.  Delayed recovery of intimate samples of body 
fluids may result in further metabolism prior to obtaining the sample, 
reducing the chances of correctly identifying any drugs present at the 
time of an incident. 
The purpose of this experiment is to determine if drugs of abuse 
can be detected in dried bloodstains by either lateral flow immunoassay 
or gas chromatography-mass spectrometry.  Blood is the most common 
biological fluid found at crime scenes and is likely to be the most 
probative as a result. While immunoassay cards for drugs are designed 
to work with urine, it is hypothesized that they will also function with 
blood as a matrix, including dried bloodstains that are collected from 
crime scenes.   
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2. MATERIALS AND METHODS 
 For the purposes of this experiment, five drugs of abuse were 
chosen as analytes of interest.  Drugs were chosen initially by the 
commercial availability of lateral flow immunoassay cards designed to 
test for their presence.  For each drug, one compound, either the drug 
itself or a major metabolite, was chosen based on the detection cutoff of 
the cards as published by the manufacturer.  The five analytes chosen 
were d-amphetamine, cocaine, morphine-3-β-D-glucuronide (an opiate 
metabolite), phencyclindine (PCP) and 11-nor- Δ9-tetrahdrocannabinol-
6COOH (a metabolite of tetrahydrocannabinol [THC], the primary active 
component of marijuana).  This list is in no way exhaustive of drugs that 
may be found in cases involving the use and abuse of drugs, or those 
drugs that may be testable using these methods.   If these methods are 
successful, they could be expanded to detect other drugs of abuse in 
dried blood samples. 
 Extraction solvents were chosen based on their range of polarity: 
water being the most polar, chloroform being the least.   Abacus 
Diagnostics (ABA) Hematrace® Extraction Buffer was chosen as an 
extraction solvent for the immunoassay portion of the experiment with 
the idea that when preliminary testing was performed for blood 
identification, remaining volumes of the extraction buffer could be used 
for drug testing, resulting in reduced sample use.  Organic solvents were 
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required for extraction for GCMS samples because of the requirements of 
the GC-MS system, which does not function with aqueous based 
injections. 
2.1. Lateral Flow Immunoassay Testing 
2.1.1. Volume Testing and Interference Testing 
 Multi-drug screen test cards (DOA-154, Medical Disposables (MD), 
Orlando, FL, US) that detect cocaine, marijuana, opiates, amphetamine, 
and phencyclidine were used. They are designed to be dipped directly 
into a urine sample for the purposes of drug detection.  With the use of 
dried bloodstains, a different approach was required for the introduction 
of sample onto the test strip.  Pipetting sample extracts directly onto the 
base of the absorbent strip was chosen as the most straightforward 
method for extract introduction.  To that end, the volume required for the 
test to give results needed to be determined. 
 The volumes tested were as follows: 100 microliters (µL), 50 µL, 43 
µL, 37 µL, and 25 µL. This was achieved by pipetting differing amounts of 
ABA Hematrace® Extraction Buffer (Abacus Diagnostics, West Hills, CA, 
US) onto the test strip and observing which volumes traversed past the 
test and control regions of the cards; cards were observed after 5 
minutes following sample introduction.  If a volume of buffer migrated 
past the control and test regions, half of that volume was tested.  If a 
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volume of buffer did not reach the test and control regions, a volume 
halfway between it and the next highest volume was tested.  
A 100µL sample volume was chosen for further sections of the 
experiment due to inconsistency issues with lower volumes. 
 A 1:2:3 mixture of methanol, drug-free blood, and ABA Extraction 
Buffer was created to roughly represent ratios of all components that 
would be present in final extracts.  This mixture was then run on the test 
cards to determine if any of these components would result in a false 
positive result or any other interference with the validity of the testing. 
2.1.2. Card Limits of Detection in Blood 
 Certified drug free blood (UTAK Laboratories, Inc., Valencia, CA, 
US) was spiked with analytes of interest (Cerriliant Analytical Reference 
Standards, Round Rock, TX, US; Cayman Chemical Ann Arbor, MI).  
Spiked blood samples were then diluted with ABA Extraction Buffer, 
yielding final concentrations based on the limits of detection reported in 
the manufacturer’s technical sheet [43] for the immunoassay cards. After 
preparation, 100 µL of the resulting samples were pipetted onto the lane 
on the card devoted to its drug.  After five minutes the tests were read: 
two lines were recorded as negative, one line was recorded as positive. 
Each drug was tested at multiple concentrations (Table 1) to 
determine the concentration below which that drug would not yield a 
positive result.   
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Table 1. Limit of Detection Testing Concentrations. Final concentrations of spiked 
blood samples diluted with ABA Extraction Buffer and pipetted onto the absorbent strip 
of the immunoassay cards. 
Drug Conc. 
1 
Conc. 
2 
Conc. 
3 
Conc. 
4 
Conc. 
5 
Conc. 
6 
Conc. 
7 
D-
Amphetamine 
1000 
ng/ 
mL 
2000 
ng/ 
mL 
3000 
ng/ 
mL 
4000 
ng/ 
mL 
5000 
ng/ 
mL 
N/A N/A 
Cocaine 
100 
ng/ 
mL 
250 
ng/ 
mL 
500 
ng/ 
mL 
750 
ng/ 
mL 
N/A N/A N/A 
Morphine 3-ß-
D-glucuronide 
1000 
ng/ 
mL 
2000 
ng/ 
mL 
3000 
ng/ 
mL 
4000 
ng/ 
mL 
N/A N/A N/A 
Phencyclidine 5 ng/ 
mL 
10 
ng/ 
mL 
25 
ng/ 
mL 
50 
ng/ 
mL 
N/A N/A N/A 
11-nor-∆9-
carboxy-THC 
5 ng/ 
mL 
10 
ng/ 
mL 
25 
ng/ 
mL 
50 
ng/ 
mL 
100 
ng/ 
mL 
250 
ng/ 
mL 
350 
ng/ 
mL 
 
If none of the tested concentrations yielded a positive result, higher 
concentrations were tested.  Any secondary line, regardless of faintness, 
was considered a negative result.  Any card that yielded no control line 
was considered inconclusive. 
2.1.3. Drying Study on White Cotton 
 Two concentrations were chosen for each drug: the detection cutoff 
determined above and one higher concentration (Table 2).  Drug-free 
blood was spiked at the chosen concentration for each drug.  A volume of 
100µL of each blood sample was pipetted onto a TX304 TexWipe Cotton 
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Wiper (Thermo Fisher Scientific, Waltham, MA, US), in triplicate, for each 
of two time points.  One set of swatches was allowed to dry uncovered at 
room temperature for 6 hours, and the other for 24 hours. 
Table 2. Dried Spiked Blood Sample Concentrations on White Cotton. 
Concentrations of drugs in blood spotted onto cotton swatches and allowed to dry prior 
to running on immunoassay cards. 
Drug Low Concentration High Concentration 
D-Amphetamine 2000 ng/mL 3000 ng/mL 
Cocaine 750 ng/mL 1500 ng/mL 
Morphine 3-ß-D-
glucuronide 
3000 ng/mL 4000 ng/mL 
Phencyclidine 10 ng/mL 25 ng/mL 
11-nor-∆9-carboxy-THC 100 ng/mL 250 ng/mL 
After drying, the stains were cut out in their entirety using 
scissors, and placed in a microcentrifuge tube.  One hundred microliters 
of ABA Extraction Buffer was pipetted into microcentrifuge tubes 
(Thermo Fisher Scientific, Waltham, MA, US), which were then placed on 
a shaker for 1 hour for extraction.  After 1 hour, the stains were placed 
in spin baskets (Corning Life Sciences, Corning, NY, US) and centrifuged 
into their respective tubes for 10 minutes at 13,200 revolutions per 
minute (rpm) to recover as much of the extraction product as possible. 
 The resulting extracts were pipetted directly onto the absorbent 
strip of the cards and allowed to sit for 5 minutes.  Tests were then 
observed to determine a positive (one line) or negative (two lines) result. 
Any card with no visualized control line was considered inconclusive. 
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 The spiked sample drying experiment was repeated using methanol 
as an extraction solvent instead of the ABA Extraction Buffer. 
 For drugs with reported physiological concentrations (Table 3) 
above the card detection limit, drug-free blood was spiked to those 
concentrations and spotted onto cotton swatches, in triplicate, for each 
of two time points. One set was allowed to dry for 6 hours, the other for 
24 hours.  The stains were extracted using the same method as above, 
using the ABA Extraction Buffer as the extraction solvent.  Extracts were 
run on the cards, left to sit for 5 minutes, and results were recorded. 
Table 3. Physiological Concentrations. Reported physiological concentrations [11].  
PCP and Cocaine are above card limit of detection and were spiked into blood at those 
concentrations. 
Drug Physiological Concentration 
D-Amphetamine 66.6 ng/mL 
Cocaine 1260 ng/mL 
Morphine 3-ß-D-glucuronide 368.22 ng/mL 
Phencyclidine 240 ng/mL 
11-nor-∆9-carboxy-THC 29.7 ng/mL 
 
2.2. Gas Chromatography Mass Spectrometry 
Chromatographic separation was carried out using an Agilent 
7890A GC and MS was an Agilent 5975C EI-MS (Agilent Technologies, 
Santa Clara, CA, US).  All tests were run using an Agilent HP5MS, 5% 
Phenyl Methyl Silox 30 meter (m) x 250 micrometer (µm) x 0.25µm 
column, and using helium as the carrier gas.  All injections were 
splitless.  For all injections, the MS was run in scan mode. 
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2.2.1. Method Development 
 For each of the following methods, drug standards for each analyte 
were prepared in a 100µg/mL solution and placed in a GC vial with 
insert and placed on the auto sampler. 
 Initial testing utilized a 42.5 minute method (Method 1) with an 
inlet temperature of 250°C.  Oven temperature started at 50°C ramping 
to 200°C at 20°C per minute (°C/min) then to 250°C at 5°C/min then to 
300°C at 2°C/min.  Once compound RT was determined for those 
compounds that could be detected (PCP, amphetamine, and cocaine), the 
method was optimized to achieve a shorter run time while maintaining 
effective separation and detection of compounds. 
 The augmented method (Method 2) had the same inlet temperature 
but shortened the method to 15 minutes from 42.5.  The oven 
temperature was set at 50°C, ramping to 240°C at 30°C/min then to 
300°C at 15°C/min.  This achieved separation and detection for the three 
compounds detected by the previous method (amphetamine, cocaine, 
and PCP. 
 For those compounds that were not detectable using the above 
methods a cool inlet inject method was attempted.  This method (Method 
3) utilized an inlet at 50°C, but using the same oven parameters as the 
second method described above. 
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2.2.1.1. Derivitization 
 For those compounds that were not detectable using any of the 
above methods, derivitization was attempted. 
 For THC, a total of three separate derivitizations were attempted. 
The first utilized PFPA and PFPOH (Sigma Aldrich, St. Louis, MO, US) 
[44]. One hundred microlitersof 1µg/mL 11-nor-∆9-carboxy-THC was 
placed in a microcentrifuge tube and evaporated to dryness under a 
stream of nitrogen.  50µL of PFPOH was then added to the tube, followed 
by 50µL of PFPA.  Tubes were placed on a heating block at 85°C for 30 
minutes.  Samples were transferred to GC vials with lines and run using 
both Method 2 and Method 3. 
 The second derivitization utilized BSTFA [45].  One hundred 
microlitersof 1 milligram per milliliter (mg/mL) 11-nor-∆9-carboxy-THC 
was placed into two separate tubes.  50µL of BSTFA +1% 
trimethylchlorosaline (TMCS) (Sigma Aldrich, St. Louis, MO, US) was 
added to each tube.  30µL of ethyl acetate was added to one of the tubes.  
Samples were placed on a heating block for 30 minutes at 70°C.  
Following heating, samples were transferred to GC vials with liners 
(Thermo Fisher Scientific, Waltham, MA, US) and run using Method 2 
and Method 3 described above. 
 The third derivitization used MSTFA [46].  One hundred microliters 
of 1mg/mL 11-nor-∆9-carboxy-THC was placed in a microcentrifuge 
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tube.  75µL of MSTFA (Sigma Aldrich, St. Louis, MO, US) were then 
added the tube, and the tube was placed on a heating block at 70°C for 
30 minutes.  Samples were then transferred to GC vials and run using 
Method 2 and Method 3. 
 For the detection of morphine 3-ß-D-glucuronide, derivitizations 
with PFPOH [47] and BSTFA [48] were carried out.  For derivitization 
with PFPOH, 100 µL of 1µg/mL morphine 3-ß-D-glucuronide was placed 
in a tube with 100 µL of PFPOH and heated on a heating block for 30 
minutes at 85°C.  For derivitization with BSTFA, 100µL of 1mg/mL 
morphine 3-ß-D-glucuronide was placed in a tube with 50 µL of 
BSTFA+1%TMCS and heated at 70°C for 30 minutes.  After heating, all 
samples were transferred to GC vials with liners and run on Method 2 
and Method 3. 
2.2.2. Substrate Control Testing 
 To determine if the substrate was causing any interference, a 
section of unstained cotton swatch was cut out and placed in a 
microcentrifuge tube (in sextuplet). One hundred microliters of methanol 
was added to three of the tubes and 100 µL of chloroform was added to 
the other three.  Tubes were then placed on a mixing plate for 5 minutes.  
Samples were placed in spin baskets and centrifuged for 10 minutes at 
13,200 rpm.  Resulting extracts were transferred to GC vials and run on 
Method 2 above. 
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2.2.3. Matrix Match Extraction Controls 
 To determine how well methanol and chloroform extractions 
recovered the analytes, certified drug-free blood was spiked to 1µg/mL 
with each drug. One hundred µL of spiked blood was then pipetted, in 
sextuplet, onto cotton swatches and allowed to dry for 10 minutes 
exposed at room temperature.  Entire stains were then cut out and 
placed in microcentrifuge tubes. One hundred µL of methanol was added 
to half of the tubes and 100 µL of chloroform was added to the other half 
(in triplicate for each solvent with each drug).  These tubes were set to 
extract on a mixing plate for 5 minutes.  Excised stains were transferred 
to spin baskets and spun in a centrifuge for 10 minutes at 13,200 rpm to 
recover extraction solvent.  Morphine 3-ß-D-gluucuronide extracts were 
subjected to BSTFA derivitization discussed above.  All extracts were 
transferred to GC vials and run on GC Method 2. 
2.2.4. Drying Study on White Cotton 
Certified drug-free blood was spotted (unspiked), in sextuplet, onto 
white cotton swatches for each of two time points and allowed to sit at 
room temperature, one set drying for 6 hours, the other for 24 hours.  
After drying, stains were cut out and placed in microcentrifuge tubes.  
100 µL of methanol was added to half of the tubes and 100 µL of 
chloroform was added to the other (3 for each solvent, at each time point) 
and placed on a mixing plate for 5 minutes.  Excised stains were then 
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placed in spin baskets and spun for 10 minutes at 13,200 rpm to recover 
as much extract solvent as possible. 
For all detectable drugs, certified drug-free blood was spiked to 
concentrations consistent with those tested on the immunoassay cards 
(Table 2) and physiological concentration (Table 3) regardless of the cards 
ability to detect those concentrations.  One hundred microliters of blood 
was pipetted onto cotton swatches, in sextuplet, for each of two time 
points.  One set of stains was allowed to dry, exposed, at room 
temperature for 6, the other for 24 hours. 
 After drying, stains were were cut out and processed in the same 
manner as described in the Matrix Match Control section above. 
 Morphine 3-ß-D-glucuronide samples were subjected to BSTFA 
derivitization outlined above.  All extracts were then transferred to GC 
vials with liners and run on Method 2 discussed above. 
 Extracted ion chromatograms were utilized to identify analytes 
from final spectra. 
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3. RESULTS  
3.1. Lateral Flow Immunoassay Testing 
3.1.1. Volume Testing and Interference Testing 
 When 100 µL of ABA Extraction Buffer was pipetted onto the test 
strip, the liquid front passed both the test and control regions each time.  
When 50 µL or 43 µL were used the fluid front’s travel distance was 
inconsistent, sometimes passing the test and control regions, and 
sometimes not reaching them at all.   37 µL volumes would not reach the 
testing and control regions within the testing time.  If left for over an 
hour, 37 µL samples did reach the testing and control regions.  25 µL 
samples never reached the testing and control regions. 
 Blood/ABA Buffer/methanol combinations showed no signs of 
interference with the mechanisms of the immunoassay cards.  All results 
were negative with no visible fading in the test or control lines. 
3.1.2. Card Limits of Detection in Blood 
 The limits of detection for each drug in blood on the immunoassay 
cards were determined (Table 4). 
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Table 4. Limit of Detection Results. Results of limit of detection study using 
concentrations from Table 1, “-“ indicates a negative test, “+” indicates a positive test. 
Drug Conc. 1 
Conc. 
2 
Conc. 
3 
Conc. 
4 
Conc. 
5 
Conc. 
6 
Conc. 
7 
D-
Amphetamine 
+ + + + + N/A N/A 
Cocaine - - - + N/A N/A N/A 
Morphine 3-ß-
D-glucuronide - - + + N/A N/A N/A 
Phencyclidine - + + + N/A N/A N/A 
11-nor-∆9-
carboxy-THC 
- - - - + + + 
 
3.1.3. Drying Study on White Cotton 
 When water was used as the extraction solvent, some drugs were 
detectable after 6 hours of drying at room temperature.  After 24 hours, 
phencyclidine and d-amphetamine were both detectable: one at its 
testing concentrations (d-amphetamine) and one at its physiological 
concentration (PCP) (Table 5). 
Table 5. Immunoassay Card Drying Study Results.  
Concentration Low Conc. High Conc. Physiological Conc. 
Drying Time 6 
Hours 
24 
Hours 
6 
Hours 
24 
Hours 
6 
Hours 
24 
Hours 
Drug       
D-
Amphetamine + + + + N/A N/A 
Cocaine - - - - - - 
Morphine 3-ß-
D-glucuronide - - - - N/A N/A 
Phencyclidine - - + - + + 
11-nor-∆9-
carboxy-THC - - - - N/A N/A 
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 When methanol was used as an extraction solvent for dried 
bloodstains, testing was inconclusive.  Methanol alone would not travel 
the length of the strip, appearing to evaporate before reaching the test or 
control lines. 
3.2. Gas Spectrometry-Mass Spectrometry 
3.2.1. Method Development 
Method 1 was able to separate and detect d-amphetamine, cocaine 
and PCP, all with RTs less than 15 minutes, with no separation or 
detection of morphine 3-ß-D-glucuronide, or 11-nor-∆9-carboxy THC.  As 
a result, Method 2 was created for detecting the three analytes that 
yielded positive results from Method 1while also drastically reducing the 
time required for analysis.  Method 2 was able to detect standards of d-
amphetamine (Figure 8), cocaine and PCP (Appendix A).   
Method 3, a cool inlet injection method, did not change separation 
or detection ability for either morphine 3-ß-D-glucuronide or 11-nor-∆9-
carboxy THC. 
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Figure 8. GC and MS Spectral Data for Amphetamine.  GC/MS data for d-
amphetamine run on Method 2 with a RT of 5.418 minutes and major mass fragments 
at 44.2, 91.1, and 65.1. 
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3.2.1.1. Derivitization 
 After derivitization morphine 3-ß-D-glucuronide standard was 
separable and detectable using Method 2 (Figure 9). 
 
Figure 9. Morphine Derivitization with BSTFA + 1%TMCS.  GC/MS data of a 
morphine 3-ß-D-glucuronide standard after BSTFA derivitization run on Method 2 with 
RT 12.604 minutes and major ions present at 285.1, 162.1, and 42.1. 
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 No attempted derivitizations allowed for 11-nor-∆9-caboxy-THC to 
become separated or detected by Method 2 or Method 3. 
3.2.2. Substrate Control Testing 
 Substrate testing did not yield any peaks that would interfere 
directly with the detection of the analytes for which testing was being 
carried out (Figure 10). 
 
Figure 10. GC Spectrum of White Cotton. GC data or negative substrate control 
sample. 
3.2.3. Matrix Match Extraction Controls 
 Cocaine  (Figure 11), and PCP (Appendix A) were both detectable 
when extracted using either methanol or chloroform.  D-amphetamine 
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and derivitized morphine 3-ß-D glucuronide were not detectable in either 
extraction process. 
 
Figure 11. Matrix Match Cocaine Standard Data. Matrix match extraction data for 
cocaine spiked blood. A) Methanol extraction GC data. B) Methanol extraction extracted 
ion chromatogram (ions: 82 and 182). C) Methanol extraction cocaine peak mass 
spectrum (RT: 10.822 minutes) D) Chloroform extraction GC data. E) Chloroform 
extraction extracted ion chromatogram (ions: 82 and 182). F) Chloroform extraction 
cocaine peak mass spectrum (RT: 10.816 minutes) 
A
B
C
D
E
F
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3.2.4. Drying Study on White Cotton 
 The GC/MS was able to detect some of the tested analytes, even 
after 24 hours of drying in blood on white cotton (Table 6, Table 7). 
Table 6. GC/MS Drying Study Methanol Extraction Data. Results of GC/MS testing 
on dried bloodstains using methanol as an extraction solvent. 
Concentration Low Conc. High Conc. Physiological Conc. 
Drying Time 
6 
Hours 
24 
Hours 
6 
Hours 
24 
Hours 
6 
Hours 
24 
Hours 
Drug       
D-
Amphetamine + - + - - - 
Cocaine + + + + + + 
Morphine 3-ß-
D-glucuronide - - - - - - 
Phencyclidine - - - - + + 
11-nor-∆9-
carboxy-THC 
N/A N/A N/A N/A N/A N/A 
 
Table 7. GC/MS Drying Study Chloroform Extraction Data. Results of GC/MS 
testing on dried bloodstains using chloroform as an extraction solvent. 
Concentration Low Conc. High Conc. Physiological 
Conc. 
Drying Time 
6 
Hours 
24 
Hours 
6 
Hours 
24 
Hours 
6 
Hours 
24 
Hours 
Drug       
D-
Amphetamine - - - - N/A N/A 
Cocaine - - - - N/A N/A 
Morphine 3-ß-
D-glucuronide 
- - - - - - 
Phencyclidine - - - - N/A N/A 
11-nor-∆9-
carboxy-THC 
N/A N/A N/A N/A N/A N/A 
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4. DISCUSSION 
4.1. Lateral Flow Immunoassay Testing 
 As PCP was the only drug detectable by the lateral flow 
immunoassay testing at physiological concentrations, the use of these 
cards for the purposes of testing for drugs of abuse in dried bloodstains 
is not currently a viable method.  If the lateral flow immunoassay cards 
could be manufactured with more sensitive limits of detection, however, 
it is possible that this method could be utilized to detect drugs of abuse 
in dried blood.  The ability of the cards to detect PCP (the drug with the 
lowest limit of detection, by far) indicates that the cards are capable of 
detecting drugs in dried blood, lending credence to the problem being one 
of sensitivity and not feasibility. 
It is also possible that switching from the competitive binding form 
to the sandwich form of lateral flow cards may have some effect on 
sensitivity.  While the competitive assay functionally eliminates the high-
dose hook effect (a known issue with the sandwich style cards resulting 
in a false negative due to an exceptionally high quantity of the target 
analyte [29]), it appears that this would likely not be a consistent worry 
in a forensic setting.  In a clinical setting, for which the cards used in 
this experiment were originally designed, the cards would be dipped into 
a relatively large urine sample.  In this case most or all of the antibodies 
in the sample well may become saturated prior to meeting the test line, 
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resulting in a possible false negative in a sandwich style card. In 
sandwich immunoassays, the analyte flows up the strip due to capillary 
action, and binds to the membrane-bound (immobile) antibody as well 
the free-floating antibodies moving along the strip with the sample.  In 
these assays, the formation of an antibody-antigen-antibody “sandwich” 
results in the visualization of a secondary line at the test region of the 
strip due to an accumulation of dye-labeled antibody.  In these tests, the 
presence of two lines indicates a positive test for the analyte of interest 
(Figure 6) [38].   
The second form of immunoassay test strip is based on competitive 
binding.  In these, a cluster of the analyte of interest is bound to the 
testing membrane at the test region.  When a sample with little or no 
analyte is introduced, the free-floating, dye-labeled antibodies travel 
along the strip and bind to the testing area, causing the visualization of a 
secondary line. Here, a secondary line indicates a negative test.  In a 
sample containing the analyte of interest, the analyte present in the 
sample will competitively bind the free-floating, dye-labeled antibody 
before it has a chance to travel up the strip and bind to the test region. 
This will limit the number of dye-labeled antibodies that accumulate at 
the test region, resulting in no visualization of a secondary line.  This 
results in the negation of the high-dose hook effect that may cause 
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issues with the sandwich style cards.  A single line at the control region 
indicates a positive result for the analyte of interest (Figure 6) [38]. 
If the sample is first being extracted and transferred to the card as 
it was in this experiment, sample concentration would be more 
controllable by the analyst and risk of overloading the card, resulting in 
the high dose hook effect, would likely be lowered. 
 Overall, while lateral flow immunoassay testing has the potential 
for detecting drugs in dried blood, the cards evaluated are not currently 
an effective method for the detection of drugs of abuse in these types of 
samples. 
4.2. Gas Chromatography-Mass Spectrometry 
 It is possible that GC-MS could be utilized for the detection of 
some drugs in forensic bloodstains.  Both cocaine and PCP were 
detectable by GC-MS at physiological concentrations after 24 hours of 
drying.  Samples utilized in this experiment were prepared in a simple 
manner with no clean-up steps or concentration.  It is possible that 
better results may be attainable if more extensive sample preparation 
steps were taken.  Other solvents may also yield better extraction 
efficiency.  Methanol and chloroform were chosen to represent the 
extremes of a range of polarity in organic solvents and other solvents, 
such as acetone or acetonitrile, may be more useful in the extraction 
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process.  Thus, simple modifications may make it possible to detect a 
wide range or drugs and metabolites in forensic blood samples. 
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5. CONCLUSIONS 
5.1. Conclusions 
 While both lateral flow immunoassay testing and gas 
chromatography-mass spectrometry methodologies used in this project 
were not ideal for the detection of drugs of abuse in the forensic 
bloodstains both have the potential to be augmented to be functional. 
5.2. Future Research 
 This study was limited to bloodstains deposited on one substrate 
type (white cotton) and two time points since deposition (6 hours and 24 
hours).  Given that some analytes were detectable after 24 hours of 
drying, it would be prudent to continue drying studies for extended 
periods of time to determine at which point those analytes become no 
longer detectable.  The testing of other substrates may also yield different 
results due to different treatment/dying methods or even the interactions 
different fabrics may have with the analytes of interest. 
 Sandwich style lateral flow immunoassay cards may be more 
suitable for uses in a forensic setting than their competitive binding 
counterparts.  This is due to the ambiguity introduced by the competitive 
binding assays utilizing a negative correlation between metabolite 
concentration and test strip response.  When reading a lateral flow 
immunoassay card, any line regardless of how faint, must be counted as 
present.  For drugs at low concentrations, a competitive assay may still 
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show a line because there is not enough metabolite to saturate the 
labeled antibodies (false negative).  In a sandwich style card a small 
amount of metabolite may still cause a positive response on the card in 
the form of a faint, yet present, line.  Also the production and use of 
more sensitive antibodies may also help increase sensitivity of the cards. 
 For the purposes of GC-MS, the use of other solvents and/or 
sample preparation techniques may yield better results.  This could 
include the use of acetone or acetonitrile, which would broaden the range 
of polarity of organic solvents tested.  Water is also possible but if used 
would require an evaporation to dryness and reconstitution step, adding 
to sample preparation time.  The use of an evaporation to dryness step is 
not limited to solvents incompatible with GC/MS analysis but could also 
be utilized for the purposes of increasing effective concentration of 
analytes of interest by reconstituting in a solvent volume smaller than 
the starting sample extraction volume.  This could possibly be used to 
help with detection in samples with lower concentrations.  The use of 
SIM mode for MS detection may also help to trim out extraneous data 
and more easily identify ions that would otherwise be lost in noise, 
helping lower the detection threshold. 
Other testing methods such as direct analysis in real time (DART), 
direct sample analysis (DSA), high performance liquid chromatography 
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(HPLC) or time of flight (TOF) mass spectrometry may yield better or 
faster results as well. 
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APPENDIX A:  GAS CHROMATOGRPHY MASS SPECTROMETRY DATA 
 
 
 Drug Standards 
 
 
Figure A. Amphetamine Standard GC/MS Data. GC and MS data for d-amphetamine 
standard. 
 
Figure B. Cocaine Standard GC/MS Data. GC and MS data for cocaine standard. 
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Figure C. Morphine Standard Derivative GC/MS Data.  GC and MS data for 
morphine 3-ß-D-glucuronide standard. 
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Figure D. Phencyclidine Standard GC/MS Data. GC and MS data for phencyclidine 
standard. 
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Drying Studies (Negative Results Not Shown) 
 
Amphetamine 
 
 
Figure E. Amphetamine Drying Study MS Data. MS data following methanol 
extraction after 6 hours of drying at room temperature. A) Low concentration, extracted 
ion chromatogram (ions: 44, 91 and 65). B) Low concentration d-amphetamine peak 
mass spectrum (RT: 5.669). C) High concentration, extracted ion chromatogram (ions: 
44, 91 and 65). D) High concentration d-amphetamine peak mass spectrum (RT: 5.657). 
  
A
B
C
D
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Cocaine 
 
 
Figure F. Cocaine Drying Studies MS Data. Extracted ion chromatograms (ions: 2, 
182 and 303) and peak mass spectra for low conc. at 6 hours of drying (RT: 10.827 
minutes), low conc. at 24 hours of drying (RT: 10.821 minutes), high conc. at 6 hours of 
drying (RT: 10.822 minutes), high conc. at 24 hours of drying (RT: 10.822 minutes), 
physiological conc. at 6 hours of drying (RT: 10.827 minutes), physiological conc. at 24 
hours of drying (RT: 10.827 minutes). 
Phys. Conc.
24 Hours
Low Conc.
6 Hours
High Conc.
6 Hours
Phys. Conc.
6 Hours
Low Conc.
24 Hours
High Conc.
24 Hours
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Phencyclidine 
 
 
Figure G. Phencyclidine Drying Study MS Data. MS data following methanol 
extraction of physiological concentration. A) 6 hour dry, extracted ion chromatogram 
(ions: 91, 200 and 242). B) 6 hour dry phencyclidine peak mass spectrum (RT: 9.020). 
C) 24 hour dry, extracted ion chromatogram (ions: 91, 200 and 242). D) 24 hour dry 
phencyclidine peak mass spectrum (RT: 9.032). 
D
C
B
A
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